Results 41 to 50 of about 299 (109)

Experimental and Ab Initio Characterization of Mononuclear Molybdenum Dithiocarbamates in Lubricant Mixtures. [PDF]

Langmuir, 2021
Losi G, Peeters S, Delayens F, Vezin H, Loehlé S, Thiebaut B, Righi MC.   +6 more
europepmc   +1 more source

Issue Information

JEADV Clinical Practice, Volume 3, Issue 1, Page 1-5, March 2024.
wiley   +1 more source

Influence of Malnutrition on Outcome after Hip Fractures in Older Patients. [PDF]

J Pers Med, 2023
Millrose M, Schmidt W, Krickl J, Ittermann T, Ruether J, Bail HJ, Gesslein M.   +6 more
europepmc   +1 more source

Evaluation of stress markers in horses during hippotherapy sessions in comparison to being ridden by beginners. [PDF]

Anim Welf, 2023
Potier JF, Louzier V.
europepmc   +1 more source

High Prevalence of Anti-Severe Acute Respiratory Syndrome Coronavirus 2 (Anti-SARS-CoV-2) Antibodies After the First Wave of Coronavirus Disease 2019 (COVID-19) in Kinshasa, Democratic Republic of the Congo: Results of a Cross-sectional Household-Based Survey. [PDF]

Clin Infect Dis, 2022
Nkuba AN, Makiala SM, Guichet E, Tshiminyi PM, Bazitama YM, Yambayamba MK, Kazenza BM, Kabeya TM, Matungulu EB, Baketana LK, Mitongo NM, Thaurignac G, Leendertz FH, Vanlerberghe V, Pelloquin R, Etard JF, Maman D, Mbala PK, Ayouba A, Peeters M, Muyembe JT, Delaporte E, Ahuka SM.   +22 more
europepmc   +1 more source

Efficacy, safety, and immunogenicity of a booster regimen of Ad26.COV2.S vaccine against COVID-19 (ENSEMBLE2): results of a randomised, double-blind, placebo-controlled, phase 3 trial. [PDF]

Lancet Infect Dis, 2022
Hardt K, Vandebosch A, Sadoff J, Le Gars M, Truyers C, Lowson D, Van Dromme I, Vingerhoets J, Kamphuis T, Scheper G, Ruiz-Guiñazú J, Faust SN, Spinner CD, Schuitemaker H, Van Hoof J, Douoguih M, Struyf F, ENSEMBLE2 study group.   +17 more
europepmc   +1 more source

Novel LOX Variants in Five Families with Aortic/Arterial Aneurysm and Dissection with Variable Connective Tissue Findings. [PDF]

Int J Mol Sci, 2021
Van Gucht I, Krebsova A, Diness BR, Laga S, Adlam D, Kempers M, Samani NJ, Webb TR, Baranowska AA, Van Den Heuvel L, Perik M, Luyckx I, Peeters N, Votypka P, Macek M, Meester J, Van Laer L, Verstraeten A, Loeys BL.   +18 more
europepmc   +1 more source

Clinical Severity of SARS-CoV-2 Omicron Variant Compared with Delta among Hospitalized COVID-19 Patients in Belgium during Autumn and Winter Season 2021-2022. [PDF]

Viruses, 2022
Van Goethem N, Chung PYJ, Meurisse M, Vandromme M, De Mot L, Brondeel R, Stouten V, Klamer S, Cuypers L, Braeye T, Catteau L, Nevejan L, van Loenhout JAF, Blot K.   +13 more
europepmc   +1 more source

Two Years of Genomic Surveillance in Belgium during the SARS-CoV-2 Pandemic to Attain Country-Wide Coverage and Monitor the Introduction and Spread of Emerging Variants. [PDF]

Viruses, 2022
Cuypers L, Dellicour S, Hong SL, Potter BI, Verhasselt B, Vereecke N, Lambrechts L, Durkin K, Bours V, Klamer S, Bayon-Vicente G, Vael C, Ariën KK, De Mendonca R, Soetens O, Michel C, Bearzatto B, Naesens R, Gras J, Vankeerberghen A, Matheeussen V, Martens G, Obbels D, Lemmens A, Van den Poel B, Van Even E, De Rauw K, Waumans L, Reynders M, Degosserie J, COVID-19 Genomics Belgium Consortium, Maes P, André E, Baele G.   +33 more
europepmc   +1 more source

Safety and efficacy of intravenous thrombolysis in stroke patients on prior antiplatelet therapy in the WAKE-UP trial. [PDF]

Neurol Res Pract, 2020
Frey BM, Boutitie F, Cheng B, Cho TH, Ebinger M, Endres M, Fiebach JB, Fiehler J, Ford I, Galinovic I, Königsberg A, Puig J, Roy P, Wouters A, Magnus T, Thijs V, Lemmens R, Muir KW, Nighoghossian N, Pedraza S, Simonsen CZ, Gerloff C, Thomalla G, WAKE-UP investigators.   +23 more
europepmc   +1 more source